ファージ療法:生物学的メカニズムから将来の方向へ
Steffanie A Strathdee1, Graham F Hatfull2, Vivek K Mutalik3
1Center for Innovative Phage Applications and Therapeutics, Division of Infectious Disease and Global Public Health, University of California, San Diego, La Jolla, CA 92093-0507, USA.
Cell
|January 7, 2023
まとめ
バクテリオファージ (ファージ) 治療は,抗菌剤耐性が高まっているため,天然の細菌捕食者を用いて,牽引力を獲得しています. このレビューは,フェーグのメカニズム,応用,効果的な治療開発の課題をカバーしています.
科学分野:
- 微生物学
- バイオテクノロジー
- 感染症
背景:
- 抗菌剤耐性の増加により 新しい治療戦略が必要になります
- バクテリオファージは 自然に生じる細菌の捕食者であり 抗生物質の有望な代替品です
- ファージ療法では,リチンの活性,宿主特異性,および安全性について慎重に検討する必要があります.
研究 の 目的:
- バクテリオファージ治療の現状を見直すため
- 生物学的メカニズム,臨床的応用,そして課題について議論する.
- 治療用ファグの開発の将来的な方向性を探求する.
主な方法:
- バクテリオファージの研究に関する包括的な文献レビュー.
- 細菌とファグの相互作用の生物学的メカニズムを分析する.
- 臨床データと規制上の検討
主要な成果:
- ファージは,特定の細菌宿主に対して強力なリティック活性を示します.
- 臨床試験の成功はファージ療法の可能性を強調しています
- 課題には,特徴付け,配信,規制上の障害が含まれています.
結論:
- 菌根治療は 抗菌剤耐性に対抗する有効な戦略です
- 広範な臨床採用のためにさらなる研究と開発が不可欠です.
- 治療用ファグの応用を進めるには 共同努力が不可欠です
関連する概念動画
Lytic Cycle of Bacteriophages
71.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.4K
Microorganisms in Medicine and Therapeutics
137
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
137
DNA Bacteriophages
85
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
85
Lysogenic Cycle of Bacteriophages
62.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.8K
Viral Replication: Lysogenic Cycle
116
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
116
Gene Therapy
25.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.7K


